Role of the Intravoxel Incoherent Motion Diffusion Weighted Imaging in the Pre-treatment Prediction and Early Response Monitoring to Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer.

The aim of this study was to explore whether intravoxel incoherent motion (IVIM) diffusion-weighted imaging (DWI) can probe pre-treatment differences or monitor early response in patients with locally advanced breast cancer receiving neoadjuvant chemotherapy (NAC). Thirty-six patients with locally a...

Descripción completa

Detalles Bibliográficos
Publicado en:Medicine Vol. 95; no. 4; pp. 1 - 13
Autores principales: Shunan Che, Xinming Zhao, Yanghan OU, Jing Li, Meng Wang, Bing Wu, Chunwu Zhou, Che, Shunan, Zhao, Xinming, Ou, Yanghan, Li, Jing, Wang, Meng, Wu, Bing, Zhou, Chunwu
Formato: diagnostic images research tables/charts Journal Article
Publicado: Lippincott Williams & Wilkins Jan2016
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=112727737&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 112727737
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        00257974
        2S6
      jtl: Medicine
      issn: 00257974
      maglogo: N
    pubinfo:
      dt: Jan2016
      vid: 95
      iid: 4
      pid: 433
      pub: Lippincott Williams & Wilkins
      place: Baltimore, Maryland
    artinfo:
      ui:
        112727737
        112727737
        NLM26825883
        112727737
        10.1097/MD.0000000000002420
        NLM26825883
        112727737
      ppf: 1
      ppct: 12
      formats:
      tig:
        atl: Role of the Intravoxel Incoherent Motion Diffusion Weighted Imaging in the Pre-treatment Prediction and Early Response Monitoring to Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer.
      aug:
        au:
          Shunan Che
          Xinming Zhao
          Yanghan OU
          Jing Li
          Meng Wang
          Bing Wu
          Chunwu Zhou
          Che, Shunan
          Zhao, Xinming
          Ou, Yanghan
          Li, Jing
          Wang, Meng
          Wu, Bing
          Zhou, Chunwu
        affil: Department of Diagnostic Radiology, Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, PR China
      sug:
        subj:
          Breast Neoplasms Pathology
          Antineoplastic Agents, Combined Therapeutic Use
          Breast Neoplasms Drug Therapy
          Magnetic Resonance Imaging Methods
          Carcinoma, Ductal, Breast Drug Therapy
          Neoadjuvant Therapy
          Middle Age
          Carcinoma, Ductal, Breast
          Female
          Paclitaxel Administration and Dosage
          Carboplatin Administration and Dosage
          Predictive Value of Tests
          Aged
          Epirubicin Administration and Dosage
          Chemotherapy, Adjuvant
          Human
          Middle Aged: 45-64 years
          Aged: 65+ years
          Female
      ab: The aim of this study was to explore whether intravoxel incoherent motion (IVIM) diffusion-weighted imaging (DWI) can probe pre-treatment differences or monitor early response in patients with locally advanced breast cancer receiving neoadjuvant chemotherapy (NAC). Thirty-six patients with locally advanced breast cancer were imaged using multiple-b DWI with 12 b values ranging from 0 to 1000  s/mm(2) at the baseline, and 28 patients were repeatedly scanned after the second cycle of NAC. Subjects were divided into pathologic complete response (pCR) and nonpathologic complete response (non-pCR) groups according to the surgical pathologic specimen. Parameters (D, D*, f, maximum diameter [MD] and volume [V]) before and after 2 cycles of NAC and their corresponding change (Δparameter) between pCR and non-pCR groups were compared using the Student t test or nonparametric test. The diagnostic performance of different parameters was judged by the receiver-operating characteristic curve analysis. Before NAC, the f value of pCR group was significantly higher than that of non-pCR (32.40% vs 24.40%, P = 0.048). At the end of the second cycle of NAC, the D value was significantly higher and the f value was significantly lower in pCR than that in non-pCR (P = 0.001; P = 0.015, respectively), whereas the D* value and V of the pCR group was slightly lower than that of the non-pCR group (P = 0.507; P = 0.676, respectively). ΔD was higher in pCR (-0.45 × 10(-3)  mm(2)/s) than that in non-pCR (-0.07 × 10(-3)  mm(2)/s) after 2 cycles of NAC (P < 0.001). Δf value in the pCR group was significantly higher than that in the non-pCR group (17.30% vs 5.30%, P = 0.001). There was no significant difference in ΔD* between the pCR and non-pCR group (P = 0.456). The prediction performance of ΔD value was the highest (AUC [area under the curve] = 0.924, 95% CI [95% confidence interval] = 0.759-0.990). When the optimal cut-off was set at -0.163 × 10(-3)  mm(2)/s, the values for sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) were up to 100% (95% CI = 66.4-100), 73.7% (95% CI = 48.8-90.9), 64.3% (95% CI = 35.6-86.0), and 100% (95% CI = 73.2-99.3), respectively. IVIM-derived parameters, especially the D and f value, showed potential value in the pre-treatment prediction and early response monitoring to NAC in locally advanced breast cancer. ΔD value had the best prediction performance for pathologic response after NAC.
      pubtype: Academic Journal
      doctype:
        diagnostic images
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N